Tombot
Tombot, Inc. designs realistic robotic emotional support animals, primarily the lifelike puppy Jennie, to help individuals unable to care for live pets due to health adversities, cost, or living restrictions. The company's flagship product is engineered to treat Behavioral and Psychological Symptoms of Dementia (BPSD) and aims to become the first robotic animal FDA medical device and remote patient monitoring platform.
💡Notable Achievement: Tombot's robotic puppy Jennie was named a TIME Magazine 'Best Invention' of 2020 and is the first robotic animal designed to be both an FDA medical device and a remote patient monitoring platform.
Tombot Robots
Showing 1 model
Latest News & Updates
Recent articles and news about Tombot
Frequently Asked Questions
Expert answers about Tombot
Q:What is Tombot's main product?
A: Tombot's main product is Jennie, a lifelike robotic puppy designed to provide emotional support and treat Behavioral and Psychological Symptoms of Dementia (BPSD).
Q:Who is Tombot's robotic pet designed for?
A: Jennie is designed for individuals who cannot care for live pets due to health issues, cost, burden of care, or living restrictions, including seniors with dementia, children with autism, and adults coping with stress.
Q:Is Jennie an FDA-approved medical device?
A: Jennie is not yet FDA-approved but Tombot aims to be the first robotic animal to achieve FDA medical device status and become a remote patient monitoring platform.
Q:How does Jennie mimic a real puppy?
A: Jennie uses patent-pending autonomous behaviors that are uniquely interactive and mimic a real puppy, avoiding repetitive programmed actions seen in traditional animatronics.
Q:What health conditions does Jennie help treat?
A: Jennie helps treat Behavioral and Psychological Symptoms of Dementia (BPSD), including Sundowning Syndrome, as well as stress, anxiety, loneliness, depression, and pain.
Q:When was Tombot founded?
A: Tombot was founded in July 2017.
Q:Where is Tombot headquartered?
A: Tombot is headquartered in Santa Clarita, California, USA.
Q:How much funding has Tombot raised?
A: Tombot raised $6.1 million in Series A funding in 2025, with a total of $15 million raised as of Summer 2025.
Q:What makes Jennie different from other robotic pets?
A: Jennie is uniquely interactive and autonomous with patent-pending behaviors, and it is designed to be an FDA medical device and remote patient monitoring platform, unlike other robotic pets.
Q:Can Jennie reduce medication use for patients?
A: Yes, peer-reviewed studies suggest that engaging with Jennie can reduce the need for psychotropic and opioid medications by alleviating symptoms of stress, anxiety, loneliness, depression, and pain.
💡Expert Info: Compiled from verified manufacturer data and official sources. Data verified directly from official channels. For current specs, contact Tombot directly.